What We Fund
We fund research and practical supports so every child can grow into a future defined by possibility.
OUR PRIORITIES
Focused and Accountable
Usher Syndrome 1B is underfunded, yet scientifically tractable, at a pivotal moment in gene therapy research. With a small, defined patient population, every dollar has outsized impact.
Our Commitment
The Fairfield Fund is firmly committed to transparent decision-making, exemplary governance, and unwavering stewardship of our mission to improve the lives of patients living with Usher Syndrome, and particularly Usher Syndrome 1B.
Decision Making
Our independent Board uses a transparent, mission-aligned matrix to evaluate every grant. Final funding decisions are based on aggregated scores, board discussion, and consensus, ensuring each investment meets rigorous standards for impact.